- $1.37bn
- $1.35bn
- $541.32m
Annual balance sheet for CTS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 141 | 157 | 164 | 94.3 | 82.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 82.2 | 90.9 | 78.6 | 81.8 | 94.8 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 289 | 326 | 319 | 242 | 253 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 118 | 120 | 119 | 117 | 112 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 664 | 748 | 741 | 765 | 764 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 114 | 113 | 97 | 98.5 | 110 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 201 | 242 | 214 | 237 | 213 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 464 | 506 | 527 | 528 | 552 |
| Total Liabilities & Shareholders' Equity | 664 | 748 | 741 | 765 | 764 |
| Total Common Shares Outstanding |